share_log

Nephron Research Upgrades Bright Health Gr to Buy, Announces $85 Price Target

Benzinga ·  Jun 30, 2023 10:38

Nephron Research analyst Joshua Raskin upgrades Bright Health Gr (NYSE:BHG) from Hold to Buy and announces $85 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment